These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29025973)

  • 21. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
    Andoniou CE; Thien CB; Langdon WY
    Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migration of sympathetic preganglionic neurons in the spinal cord is regulated by Reelin-dependent Dab1 tyrosine phosphorylation and CrkL.
    Yip YP; Kronstadt-O'Brien P; Capriotti C; Cooper JA; Yip JW
    J Comp Neurol; 2007 Jun; 502(4):635-43. PubMed ID: 17394141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
    J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NS1-binding protein abrogates the elevation of cell viability by the influenza A virus NS1 protein in association with CRKL.
    Miyazaki M; Nishihara H; Hasegawa H; Tashiro M; Wang L; Kimura T; Tanino M; Tsuda M; Tanaka S
    Biochem Biophys Res Commun; 2013 Nov; 441(4):953-7. PubMed ID: 24220336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacity.
    Weir ME; Mann JE; Corwin T; Fulton ZW; Hao JM; Maniscalco JF; Kenney MC; Roman Roque KM; Chapdelaine EF; Stelzl U; Deming PB; Ballif BA; Hinkle KL
    FEBS Lett; 2016 Apr; 590(8):1042-52. PubMed ID: 27001024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.
    Bedford MT; Chan DC; Leder P
    EMBO J; 1997 May; 16(9):2376-83. PubMed ID: 9171351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRKL binding to BCR-ABL and BCR-ABL transformation.
    Kolibaba KS; Bhat A; Heaney C; Oda T; Druker BJ
    Leuk Lymphoma; 1999 Mar; 33(1-2):119-26. PubMed ID: 10194128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene.
    Senechal K; Halpern J; Sawyers CL
    J Biol Chem; 1996 Sep; 271(38):23255-61. PubMed ID: 8798523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
    de Jong R; van Wijk A; Heisterkamp N; Groffen J
    Oncogene; 1998 Nov; 17(21):2805-10. PubMed ID: 9840945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M; Salgia R
    Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
    Kyono WT; de Jong R; Park RK; Liu Y; Heisterkamp N; Groffen J; Durden DL
    J Immunol; 1998 Nov; 161(10):5555-63. PubMed ID: 9820532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crk family adaptors-signalling complex formation and biological roles.
    Feller SM
    Oncogene; 2001 Oct; 20(44):6348-71. PubMed ID: 11607838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis.
    Douglas JT; Johnson DK; Roy A; Park T
    Methods Enzymol; 2024; 698():301-342. PubMed ID: 38886037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
    Ishino M; Ohba T; Sasaki H; Sasaki T
    Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.
    Novokhatska O; Dergai M; Tsyba L; Skrypkina I; Filonenko V; Moreau J; Rynditch A
    PLoS One; 2013; 8(7):e70546. PubMed ID: 23936226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.